-
Posted by
Two Blokes Apr 17 -
Filed in
Stock
-
3 views
Eli Lilly said its daily obesity pill met the company's goals in the first of several closely watched late-stage trials. The pill helped Type 2 diabetes patients lower their blood sugar and body weight and showed safety on par with popular injections on the market, with some results coming in line with Wall Street's expectations.
